Lv11
30 积分 2024-11-01 加入
Chimeric Antigen Receptor T-Cell (CAR T-Cell) Therapy for Primary and Secondary Central Nervous System Lymphoma: A Systematic Review of Literature
26分钟前
已完结
Efficacy of CAR T-cell therapy is not impaired by previous bispecific antibody treatment in large B-cell lymphoma
12天前
已完结
Inotuzumab Ozogamicin and Low-Intensity Chemotherapy in Older Patients With Newly Diagnosed CD22 + Philadelphia Chromosome–Negative B-Cell Precursor Acute Lymphoblastic Leukemia
14天前
已完结
Inotuzumab ozogamicin, an anti-CD22–calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study
14天前
已完结
Graft-versus-leukaemia effect in children: chronic GVHD has a significant impact on relapse and survival
15天前
已完结
The current landscape: Allogeneic hematopoietic stem cell transplant for acute lymphoblastic leukemia
15天前
已完结
Obecabtagene Autoleucel in Adults with B-Cell Acute Lymphoblastic Leukemia
15天前
已完结
KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study
23天前
已完结
Outcomes After Brexucabtagene Autoleucel Administered as a Standard Therapy for Adults With Relapsed/Refractory B-Cell ALL
23天前
已完结
Inaticabtagene Autoleucel (CNCT19) in adult relapsed or refractory B-cell acute lymphoblastic leukemia
23天前
已完结
皖公网安备34019202002308
